论文部分内容阅读
目的探讨血浆胱氨酸蛋白酶抑制剂C水平和脑梗死之间的关联。方法选取2015年3月至2016年3月在我院诊断和治疗的48例脑梗死患者作为研究组,另外选择同期体检的健康患者48例作为常规组,通过颗粒增强免疫比浊法测定两组患者的血浆胱氨酸蛋白酶抑制剂C水平,并探讨血浆胱氨酸蛋白酶抑制剂C水平和脑梗死之间的关联。结果研究组患者的血浆胱氨酸蛋白酶抑制剂C水平比常规组高(P<0.05)。两组患者进行多元素回顾性分析,血浆胱氨酸蛋白酶抑制剂C水平有效的预测了脑梗死体积,二者关联性极强。结论血浆胱氨酸蛋白酶抑制剂C水平与脑梗死之间的关系,血浆胱氨酸蛋白酶抑制剂C升高脑梗死患者梗死面积和神经缺损程度越高,它可以有效的预测脑梗死。
Objective To investigate the relationship between plasma cystatin C level and cerebral infarction. Methods Forty-eight patients with cerebral infarction who were diagnosed and treated in our hospital from March 2015 to March 2016 were selected as study group. Forty-eight healthy subjects in the same period were selected as normal group, Patients with plasma cystatin C levels and to explore the association between plasma cystatin C levels and cerebral infarction. Results Study group patients with plasma cystatin C levels higher than the conventional group (P <0.05). A multi-element retrospective analysis of two groups of patients, plasma cystatin C levels effectively predict the volume of cerebral infarction, both extremely strong correlation. Conclusions The relationship between plasma cystatin C and cerebral infarction and plasma cystatin C in patients with elevated cerebral infarction have higher infarct size and neurological deficit, which can effectively predict cerebral infarction.